Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience

BACKGROUND: In this prospective study, the impact of granulocyte colony-stimulating factors (G-2 CSF) administered during induction treatment with bendamustine plus rituximab for indolent non- Hodgkin Llymphoma (NHL) was evaluated by comparing patients who received secondary prophylaxis with filgras...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Support Care Cancer
Main Authors: Cerchione, Claudio, De Renzo, Amalia, Di Perna, Maria, Della Pepa, Roberta, Pugliese, Novella, Catalano, Lucio, Pane, Fabrizio, Picardi, Marco
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2016
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5266775/
https://ncbi.nlm.nih.gov/pubmed/27812763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-016-3468-8
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki